Lv1
20 积分 2022-07-05 加入
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis
1天前
已完结
Misdiagnosis in Amyotrophic Lateral Sclerosis
1天前
已完结
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
4天前
已完结
Clinical efficacy and safety of efgartigimod for treatment of myasthenia gravis
9天前
已完结
Fremanezumab plus plasmapheresis in a patient with chronic migraine and myasthenia gravis: Case report of an effective treatment
9天前
已完结
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
9天前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
9天前
已完结
Conventional and emerging treatments and controversies in myasthenia gravis
9天前
已完结
Valbenazine as treatment for Huntington's disease chorea
9天前
已完结
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
9天前
已完结
鄂公网安备 42011102003731号
